Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers

S. C. Joosten, S. N. O. Odeh, A. Koch, N. Buekers, M. J. B. Aarts, M. M. L. L. Baldewijns, L. Van Neste, S. van Kuijk, L. J. Schouten, P. A. van den Brandt, V. C. Tjan-Heijnen, M. van Engeland, K. M. Smits*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Article number103
Number of pages11
JournalClinical epigenetics
Volume13
Issue number1
DOIs
Publication statusPublished - 4 May 2021

Keywords

  • Clear cell renal cell carcinoma (ccRCC)
  • Prognostic model
  • DNA methylation biomarkers
  • DNA methylation location
  • TCGA data
  • CPG ISLAND METHYLATION
  • PROMOTER METHYLATION
  • CANCER BIOMARKER
  • FREE SURVIVAL
  • HYPERMETHYLATION
  • GROWTH
  • HETEROGENEITY
  • NEPHRECTOMY
  • INHIBITION
  • EXPRESSION

Cite this